Bausch Health Companies Overview
- Year Founded
-
1959
- Status
-
Public
- Employees
-
20,300
- Stock Symbol
-
BHC
- Investments
-
69
- Share Price
-
$8.24
- (As of Friday Closing)
Bausch Health Companies General Information
Description
Bausch Health Companies Inc is a world-wide specialty pharmaceutical, consumer health, and medical device company with a focus on branded products for the gastroenterology, hepatology, neurology and dermatology markets. The company reports revenue in five segments: Salix; International; Solta Medical; Diversified Products and Bausch + Lomb. It generates maximum of its revenue from the Bausch + Lomb segment.
Contact Information
Website
www.bauschhealth.comCorporate Office
- 2150 Street Elzéar Boulevard West
- Laval, Quebec H7L 4A8
- Canada
Corporate Office
- 2150 Street Elzéar Boulevard West
- Laval, Quebec H7L 4A8
- Canada
Bausch Health Companies Timeline
Bausch Health Companies Stock Performance
As of 20-Nov-2026, Bausch Health Companies’s stock price is $8.24. Its current market cap is $3.08B with 374M shares.
(As of Friday Closing)
| Stock Price | Previous Close | 52 wk Range | Market Cap | Shares | Average Volume | EPS |
|---|---|---|---|---|---|---|
| $8.24 | $8.58 | $4.33 - $9.04 | $3.08B | 374M | 662K | -$2.25 |
Bausch Health Companies Financials Summary
As of 30-Sep-2026, Bausch Health Companies has a trailing 12-month revenue of $11.1B.
|
In Thousands, USD |
TTM 30-Sep-2026 | FY 2025 31-Dec-2025 | FY 2024 31-Dec-2024 | FY 2023 31-Dec-2023 |
|---|---|---|---|---|
| EV | 22,134,489 | 23,566,501 | 23,425,005 | 26,164,223 |
| Revenue | 11,113,000 | 10,266,000 | 9,625,000 | 8,757,000 |
| EBITDA | 2,347,000 | 3,131,000 | 2,789,000 | 2,176,000 |
| Net Income | (841,000) | 157,000 | (46,000) | (592,000) |
| Total Assets | 25,484,000 | 26,366,000 | 26,523,000 | 27,350,000 |
| Total Debt | 20,715,000 | 20,851,000 | 21,616,000 | 22,388,000 |
Bausch Health Companies Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
Bausch Health Companies Comparisons
Industry
Financing
Details
Bausch Health Companies Competitors (3)
One of Bausch Health Companies’s 3 competitors is Zydus Lifesciences, a Corporation company based in Ahmedabad, India.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Zydus Lifesciences | Corporation | Ahmedabad, India | ||||
| Evonile Pharma | Private Equity-Backed | Mumbai, India | ||||
| Novartis | Corporation | Basel, Switzerland |
Bausch Health Companies Patents
Bausch Health Companies Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| WO-2025134072-A1 | Methods for preventing, treating, or ameliorating ulcerative colitis in certain patient populations with amiselimod | Inactive | 21-Dec-2023 | ||
| US-20260240825-A1 | Topical compositions | Pending | 11-Apr-2023 | ||
| WO-2024213629-A1 | Topical compositions | Inactive | 11-Apr-2023 | ||
| US-20260224591-A1 | Use of a fixed combination of halobetasol propionate and tazarotene to treat conditions mediated by interleukin-17a | Pending | 31-Dec-2022 | ||
| WO-2024141639-A1 | Use of a fixed combination of halobetasol propionate and tazarotene to treat conditions mediated by interleukin-17a | Inactive | 31-Dec-2022 | A61K45/06 |
Bausch Health Companies Signals
Bausch Health Companies Investors
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|
Bausch Health Companies Investments & Acquisitions (69)
Bausch Health Companies’s most recent deal was a Merger/Acquisition with MID Labs. The deal was made on 09-Oct-2026.
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| MID Labs | 09-Oct-2026 | Merger/Acquisition | Surgical Devices | ||
| Vision Beauty | 01-Dec-2025 | Merger/Acquisition | Distributors/Wholesale | ||
| Durect | 11-Sep-2025 | Merger/Acquisition | Drug Discovery | ||
| Synergy Pharmaceuticals | 06-Mar-2019 | Merger/Acquisition | Other Healthcare Services | ||
| Synergy Pharmaceuticals | 31-Dec-2015 | Merger/Acquisition | Other Healthcare Services |
Bausch Health Companies ESG
Risk Overview
Risk Rating
Updated November, 17, 2026
27.72 | Med Risk
Risk Scale
A lower score indicates better sustainability
Negl
0-10
Low
10-20
Med
20-30
High
30-40
Severe
40+
Exposure
Exposure refers to the extent to which a company is exposed to different material ESG issues
Management
Management is related to actions taken to manage ESG issues
Peers Analysis
Peer performance insights compare the company’s ESG performance to the performance of selected peers to help inform future ESG decisions and drive internal performance improvements.
Global
Covered Companies
of 13,593
Rank
Percentile
Pharmaceuticals
Industry
of 852
Rank
Percentile
Pharmaceuticals
Subindustry
of 354
Rank
Percentile
Bausch Health Companies Exits (17)
Bausch Health Companies’s most recent exit was on 01-Oct-2015 from Addyi. The exit was categorized as .
| Company Name | Exit Date | Exit Type | Exit Size | Status | Buyers |
|---|---|---|---|---|---|
| Addyi | 01-Oct-2015 | Completed |
|
||
| Amoun Pharmaceutical Company | 17-Jul-2015 | Completed |
|
||
| Paragon Vision Sciences | 18-May-2015 | Completed |
|
||
| Dendreon | 23-Feb-2015 | Completed |
|
||
| Allergan (Acquired 2015) | 20-Nov-2014 | Secondary Transaction - Private | Completed |
Bausch Health Companies Affiliates
Subsidiaries (8)
| Name | Industry | Location | Year Founded |
|---|---|---|---|
| Biovail Americas Corp | Bridgewater, NJ | 2007 | |
| Onpharma | Carson City, NV | 2005 | |
| Biovail Pharmaceuticals | Bridgewater, NJ | 1997 | |
| Solta Medical | Hayward, CA | 1995 | |
| Biovail Technologies | Aliso Viejo, CA | 1988 |
Bausch Health Companies FAQs
-
When was Bausch Health Companies founded?
Bausch Health Companies was founded in 1959.
-
Where is Bausch Health Companies headquartered?
Bausch Health Companies is headquartered in Laval, Canada.
-
What is the size of Bausch Health Companies?
Bausch Health Companies has 20,300 total employees.
-
What industry is Bausch Health Companies in?
Bausch Health Companies’s primary industry is Pharmaceuticals.
-
Is Bausch Health Companies a private or public company?
Bausch Health Companies is a Public company.
-
What is Bausch Health Companies’s stock symbol?
The ticker symbol for Bausch Health Companies is BHC.
-
What is the current stock price of Bausch Health Companies?
As of 20-Nov-2026 the stock price of Bausch Health Companies is $8.24.
-
What is the current market cap of Bausch Health Companies?
The current market capitalization of Bausch Health Companies is $3.08B.
-
What is Bausch Health Companies’s current revenue?
The trailing twelve month revenue for Bausch Health Companies is $11.1B.
-
Who are Bausch Health Companies’s competitors?
Zydus Lifesciences, Evonile Pharma, and Novartis are competitors of Bausch Health Companies.
-
What is Bausch Health Companies’s annual earnings per share (EPS)?
Bausch Health Companies’s EPS for 12 months was -$2.25.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process